Birdwatch Note
2024-11-04 00:39:36 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
村上康文氏は「コスタイベに関する非科学的な根拠に基づく一方的な内容や、Meiji Seikaに関する事実と異なる情報を動画サイトで繰り返し発信している」としてMeiji Seika ファルマから批判されている「mRNAワクチン中止を求める国民連合」の副代表です。 https://www.mixonline.jp/tabid55.html?artid=77254 村上氏の発言にはワクチンの専門家によって査読された科学論文などの科学的根拠がないことに留意しましょう。
Written by 169D2EB0CE4FAED029CE904443460D0C85651746DF09A0E57E6B11180B88C5D0
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1853217121930727850
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1853235613870571694
- noteId - 1853235613870571694
- participantId -
- noteAuthorParticipantId - 169D2EB0CE4FAED029CE904443460D0C85651746DF09A0E57E6B11180B88C5D0 Participant Details
- createdAtMillis - 1730680776456
- tweetId - 1853217121930727850
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 村上康文氏は「コスタイベに関する非科学的な根拠に基づく一方的な内容や、Meiji Seikaに関する事実と異なる情報を動画サイトで繰り返し発信している」としてMeiji Seika ファルマから批判されている「mRNAワクチン中止を求める国民連合」の副代表です。 https://www.mixonline.jp/tabid55.html?artid=77254 村上氏の発言にはワクチンの専門家によって査読された科学論文などの科学的根拠がないことに留意しましょう。
Note Ratings
rated at | rated by | |
2024-11-04 08:33:58 -0600 | Rating Details | |
2024-11-04 05:59:09 -0600 | Rating Details | |
2024-11-04 03:11:29 -0600 | Rating Details | |
2024-11-03 23:17:17 -0600 | Rating Details | |
2024-11-03 22:24:47 -0600 | Rating Details | |
2024-11-03 22:09:03 -0600 | Rating Details | |
2024-11-03 21:02:36 -0600 | Rating Details | |
2024-11-03 21:00:36 -0600 | Rating Details | |
2024-11-03 20:43:20 -0600 | Rating Details | |
2024-11-03 20:42:42 -0600 | Rating Details | |
2024-11-03 20:23:53 -0600 | Rating Details | |
2024-11-03 19:55:20 -0600 | Rating Details | |
2024-11-03 19:40:48 -0600 | Rating Details | |
2024-11-03 19:28:53 -0600 | Rating Details | |
2024-11-03 19:10:12 -0600 | Rating Details | |
2024-11-03 19:07:31 -0600 | Rating Details | |
2024-11-03 18:48:45 -0600 | Rating Details | |
2024-11-04 06:48:50 -0600 | Rating Details | |
2024-11-04 05:42:40 -0600 | Rating Details | |
2024-11-04 01:48:08 -0600 | Rating Details | |
2024-11-03 21:49:47 -0600 | Rating Details | |
2024-11-03 21:47:06 -0600 | Rating Details | |
2024-11-03 21:39:25 -0600 | Rating Details | |
2024-11-03 21:12:33 -0600 | Rating Details | |
2024-11-03 20:31:16 -0600 | Rating Details | |
2024-11-03 19:46:48 -0600 | Rating Details | |
2024-11-03 19:43:06 -0600 | Rating Details | |
2024-11-03 19:39:51 -0600 | Rating Details | |
2024-11-03 20:58:46 -0600 | Rating Details | |
2024-11-03 20:43:52 -0600 | Rating Details | |
2024-11-03 19:46:37 -0600 | Rating Details | |
2024-11-03 19:33:29 -0600 | Rating Details | |
2024-11-03 19:30:25 -0600 | Rating Details | |
2024-11-03 19:29:18 -0600 | Rating Details | |
2024-11-03 19:28:05 -0600 | Rating Details | |
2024-11-03 19:26:28 -0600 | Rating Details | |
2024-11-04 12:33:54 -0600 | Rating Details | |
2024-11-04 06:31:04 -0600 | Rating Details | |
2024-11-03 21:06:44 -0600 | Rating Details | |
2024-11-03 21:00:39 -0600 | Rating Details | |
2024-11-03 20:52:07 -0600 | Rating Details | |
2024-11-03 20:26:07 -0600 | Rating Details | |
2024-11-03 19:51:06 -0600 | Rating Details | |
2024-11-03 19:47:38 -0600 | Rating Details | |
2024-11-03 19:46:20 -0600 | Rating Details | |
2024-11-03 19:08:09 -0600 | Rating Details | |
2024-11-03 18:49:27 -0600 | Rating Details |